Prestige Consumer Healthcare PBH Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| International OTC Healthcare | $47.07M-1.0% | $47.75M-7.1% | $43.36M-1.4% | $36.95M+6.1% | $47.57M+3.7% | |
| North American OTC Healthcare | $234.55M-5.8% | $235.7M-1.4% | $230.76M-3.8% | $212.58M-8.5% | $248.95M+7.7% | |
| Total revenues by Product | ||||||
| Analgesics | $28.24M-6.5% | $28.03M-9.5% | $28.73M+1.8% | $28.93M+2.3% | $30.2M+8.6% | |
| Cough & Cold | $26.29M-2.3% | $29.33M0.0% | $27.29M-6.8% | $19.01M-8.2% | $26.91M+2.8% | |
| Dermatologicals | $30.49M+4.8% | $29.64M-3.3% | $35.7M-0.4% | $30.11M-9.7% | $29.08M-5.7% | |
| Eye & Ear Care | $37.85M-19.0% | $38.6M-15.5% | $34.18M-20.1% | $32.31M-32.9% | $46.73M+6.2% | |
| Gastrointestinal | $68.35M-0.8% | $69.45M+0.7% | $64.2M+6.9% | $57.78M-0.4% | $68.88M+15.5% | |
| Oral Care | $28M+3.3% | $26.58M+15.2% | $24.77M+2.8% | $21.7M+4.5% | $27.09M+7.0% | |
| Other OTC | $5.35M+39.2% | $4.04M+16.3% | $3.06M-3.0% | $2.93M-11.2% | $3.85M+25.3% | |
| Women's Health | $57.05M-10.6% | $57.77M-0.6% | $56.2M-6.9% | $56.76M+4.0% | $63.78M+6.0% | |
| Percentage of deposits held in one location (as percent) by Geography | ||||||
| Singapore | 4%+3.0pp | —— | —— | —— | 1%-1.0pp | |
| Sydney, Australia | 18%+7.0pp | —— | —— | —— | 11%-38.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Prestige Consumer Healthcare break its business down?
- Prestige Consumer Healthcare (PBH) reports total revenues by business across 2 parts — International OTC Healthcare and North American OTC Healthcare. Each is extracted from the segment footnotes and tracked over time.
- Where does Prestige Consumer Healthcare's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Prestige Consumer Healthcare's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
